161 related articles for article (PubMed ID: 29500219)
1. RUNX transcription factors potentially control E-selectin expression in the bone marrow vascular niche in mice.
Morita K; Tokushige C; Maeda S; Kiyose H; Noura M; Iwai A; Yamada M; Kashiwazaki G; Taniguchi J; Bando T; Hirata M; Kataoka TR; Nakahata T; Adachi S; Sugiyama H; Kamikubo Y
Blood Adv; 2018 Mar; 2(5):509-515. PubMed ID: 29500219
[TBL] [Abstract][Full Text] [Related]
2. Genetic regulation of the RUNX transcription factor family has antitumor effects.
Morita K; Suzuki K; Maeda S; Matsuo A; Mitsuda Y; Tokushige C; Kashiwazaki G; Taniguchi J; Maeda R; Noura M; Hirata M; Kataoka T; Yano A; Yamada Y; Kiyose H; Tokumasu M; Matsuo H; Tanaka S; Okuno Y; Muto M; Naka K; Ito K; Kitamura T; Kaneda Y; Liu PP; Bando T; Adachi S; Sugiyama H; Kamikubo Y
J Clin Invest; 2017 Jun; 127(7):2815-2828. PubMed ID: 28530640
[TBL] [Abstract][Full Text] [Related]
3. Harnessing upregulated E-selectin while enhancing SDF-1α sensing redirects infused NK cells to the AML-perturbed bone marrow.
Sanz-Ortega L; Andersson A; Carlsten M
Leukemia; 2024 Mar; 38(3):579-589. PubMed ID: 38182818
[TBL] [Abstract][Full Text] [Related]
4. Endothelial E-selectin inhibition improves acute myeloid leukaemia therapy by disrupting vascular niche-mediated chemoresistance.
Barbier V; Erbani J; Fiveash C; Davies JM; Tay J; Tallack MR; Lowe J; Magnani JL; Pattabiraman DR; Perkins AC; Lisle J; Rasko JEJ; Levesque JP; Winkler IG
Nat Commun; 2020 Apr; 11(1):2042. PubMed ID: 32341362
[TBL] [Abstract][Full Text] [Related]
5. Shear stress-mediated adhesion of acute myeloid leukemia and KG-1 cells to endothelial cells involves functional P-selectin.
Bistrian R; Dorn A; Möbest DC; Rüster B; Ludwig R; Scheele J; Seifried E; Martin H; Henschler R
Stem Cells Dev; 2009 Oct; 18(8):1235-42. PubMed ID: 19105599
[TBL] [Abstract][Full Text] [Related]
6. Roles of the bone marrow niche in hematopoiesis, leukemogenesis, and chemotherapy resistance in acute myeloid leukemia.
Wang A; Zhong H
Hematology; 2018 Dec; 23(10):729-739. PubMed ID: 29902132
[TBL] [Abstract][Full Text] [Related]
7. Cross-talk between leukemic and endothelial cells promotes angiogenesis by VEGF activation of the Notch/Dll4 pathway.
Zhang J; Ye J; Ma D; Liu N; Wu H; Yu S; Sun X; Tse W; Ji C
Carcinogenesis; 2013 Mar; 34(3):667-77. PubMed ID: 23239744
[TBL] [Abstract][Full Text] [Related]
8. CROX (Cluster Regulation of RUNX) as a Potential Novel Therapeutic Approach.
Kamikubo Y
Mol Cells; 2020 Feb; 43(2):198-202. PubMed ID: 31991534
[TBL] [Abstract][Full Text] [Related]
9. Acute myeloid leukemia in the vascular niche.
Cogle CR; Bosse RC; Brewer T; Migdady Y; Shirzad R; Kampen KR; Saki N
Cancer Lett; 2016 Oct; 380(2):552-560. PubMed ID: 25963886
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic, genotypic, and functional characterization of normal and acute myeloid leukemia-derived marrow endothelial cells.
Pizzo RJ; Azadniv M; Guo N; Acklin J; Lacagnina K; Coppage M; Liesveld JL
Exp Hematol; 2016 May; 44(5):378-89. PubMed ID: 26851308
[TBL] [Abstract][Full Text] [Related]
11. Genetic compensation of RUNX family transcription factors in leukemia.
Kamikubo Y
Cancer Sci; 2018 Aug; 109(8):2358-2363. PubMed ID: 29883054
[TBL] [Abstract][Full Text] [Related]
12. Role of RUNX family members in transcriptional repression and gene silencing.
Durst KL; Hiebert SW
Oncogene; 2004 May; 23(24):4220-4. PubMed ID: 15156176
[TBL] [Abstract][Full Text] [Related]
13. Acute Myeloid Leukemia Chemo-Resistance Is Mediated by E-selectin Receptor CD162 in Bone Marrow Niches.
Erbani J; Tay J; Barbier V; Levesque JP; Winkler IG
Front Cell Dev Biol; 2020; 8():668. PubMed ID: 32793603
[TBL] [Abstract][Full Text] [Related]
14. The pre-TCR signal induces transcriptional silencing of the TCRγ locus by reducing the recruitment of STAT5 and Runx to transcriptional enhancers.
Tani-Ichi S; Satake M; Ikuta K
Int Immunol; 2011 Sep; 23(9):553-63. PubMed ID: 21750145
[TBL] [Abstract][Full Text] [Related]
15. MiR-181 family: regulators of myeloid differentiation and acute myeloid leukemia as well as potential therapeutic targets.
Su R; Lin HS; Zhang XH; Yin XL; Ning HM; Liu B; Zhai PF; Gong JN; Shen C; Song L; Chen J; Wang F; Zhao HL; Ma YN; Yu J; Zhang JW
Oncogene; 2015 Jun; 34(25):3226-39. PubMed ID: 25174404
[TBL] [Abstract][Full Text] [Related]
16. High acute myeloid leukemia derived VEGFA levels are associated with a specific vascular morphology in the leukemic bone marrow.
Weidenaar AC; ter Elst A; Koopmans-Klein G; Rosati S; den Dunnen WF; Meeuwsen-de Boer T; Kamps WA; Vellenga E; de Bont ES
Cell Oncol (Dordr); 2011 Aug; 34(4):289-96. PubMed ID: 21468688
[TBL] [Abstract][Full Text] [Related]
17. Runx family genes, niche, and stem cell quiescence.
Wang CQ; Jacob B; Nah GS; Osato M
Blood Cells Mol Dis; 2010 Apr; 44(4):275-86. PubMed ID: 20144877
[TBL] [Abstract][Full Text] [Related]
18. Targeting hematologic malignancies by inhibiting E-selectin: A sweet spot for AML therapy?
Uy GL; DeAngelo DJ; Lozier JN; Fisher DM; Jonas BA; Magnani JL; Becker PS; Lazarus HM; Winkler IG
Blood Rev; 2024 May; 65():101184. PubMed ID: 38493006
[TBL] [Abstract][Full Text] [Related]
19. The bone marrow microenvironment - Home of the leukemic blasts.
Shafat MS; Gnaneswaran B; Bowles KM; Rushworth SA
Blood Rev; 2017 Sep; 31(5):277-286. PubMed ID: 28318761
[TBL] [Abstract][Full Text] [Related]
20. Runx Family Genes in Tissue Stem Cell Dynamics.
Wang CQ; Mok MM; Yokomizo T; Tergaonkar V; Osato M
Adv Exp Med Biol; 2017; 962():117-138. PubMed ID: 28299655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
